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A novel common precursor approach towards both tricyclic 
and spirocyclic heterocycles is described. Cyclisations are 
based on thiyl radical/ isocyanide methodology and avoid the 
use of tin. 
Tricyclic heterocycles and their related spirocyclic congeners 
are attractive synthetic targets due to their occurrence in natural 
products and their frequent use as therapeutics.1 Nearly all 
members of these two distinct chemical series possess potent 
and widely differing biological activities and have attracted 
significant attention from both synthetic and medicinal 
chemists.1 In particular, martinelline 1 and martinellic acid 2 - 
isolated from the roots of Martinella iquitosensis, have featured 
frequently in the literature, due to their unique occurrence in 
nature and their antibiotic/antagonistic activity towards several 
G-protein coupled receptors (GPCR) systems including 
bradykinin and muscarinic receptors.2 Amongst the non-natural 
product based compounds, the related tricyclic molecule - 
NVP-BEZ235 3, which is a dual inhibitor of PI3K/mTor 
pathway serves to highlight the anticancer potential of this class 
of compound.3 Related to their tricyclic counterparts, the 
spirooxindole heterocycles have also attracted significant 
attention, not least due to their structural complexity. This 
ranges from simple members such as horsfiline 4 and 
coerulescine 5,4 through to more substituted derivatives such as 
alstonisine 6 and spirotryptostatin A 7.5,6 There have been a 
significant number of synthetic efforts directed towards 7 and 
related derivatives due to its potent antinioplastic activity via 
inhibition of the cell cycle.6 
 
 
 
Fig. 1 Spirocyclic and tricyclic heterocycles 
There have been several approaches to both these classes of 
compound using radical methodology as a result of the mild 
flexible and predictable conditions that can be used, preventing 
the need for protection/deprotection steps.7 In particular Takeda 
et al. have reported an attractive radical route to the core 
structure of Martinelline,7 whilst Beckwith and Storey have 
developed a route towards oxindoles via hydrogen atom 
abstraction using tributyltin hydride.8 Despite the large number 
of reports towards both classes of compound, many rely upon 
the use of organo-tin hydride reagents as a way of mediating 
these processes.7,8 An alternative method for the formation of 
nitrogen heterocycles that avoids the use of tin involves the 
addition of thiyl radicals to isocyanides, generating α-imidoyl 
radicals which can undergo cyclisation onto a pendant 
alkene/alkyne.9 However, there is no approach that allows for 
the synthesis of both chemical classes commencing from a 
common precursor. We now wish to disclose a novel tuneable 
approach to both tricyclic and spirocyclic heterocycles that is 
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able to select for both classes via simple modification of the 
reaction conditions. The disconnection sequence towards both 
the pyrroloquinoline core 8 and the spirocyclic structure 9 from 
reaction of the precursor 11 is shown in detail (Scheme 1).  
Scheme 1 Disconnection of the tricyclic and spirocyclic cores 
We envisaged that under suitable reaction conditions the 
intermediate α-imidoyl radical derived from addition of a thiyl 
radical to the isocyanide 11, would undergo either 6-endo or 5-
exo cyclisation to generate either the tricyclic core 8, or the 
spirocyclic structure 9 respectively. Our approach was inspired 
by the reports of Saegusa, Fukuyama and Rainier who had 
demonstrated precedent for 5-exo cyclisation, but there was 
limited evidence for successful obtention of the product of 6-
endo cyclisation.9,10 The synthesis of the cyclisation precursor 
11 commenced with iodination of methyl-4-aminobenzoate 12 
to give the palladium coupling precursor 13 in 80% yield.11 Use 
of Suzuki-Miyaura conditions for the formation of amine 15 
proved problematic with commercially available N-Boc 
pyrrole-2-boronic acid 14. However, switching to the use of 
freshly prepared 14 following the procedure of Martina,12 
amine 15 was obtained in 82% yield. Subsequent formylation 
with formic acetic anhydride,13 followed by dehydration with 
phosphorus oxychloride and diisopropylamine proceeded 
smoothly, resulting in isocyanide 11 in 79% yield.14  
 
 
 
 
 
 
 
 
 
Scheme 2 Synthesis of common cyclisation precursor 11 
With the cyclisation precursor 11 in hand, investigation of a 
range of conditions were explored in order to select for either 6-
endo or 5-exo cyclisation in a thermodynamic or kinetic manner 
respectively and the results are outlined below (Table 1).  
Table 1 Optimisation of reaction conditions for obtention of both tricyclic 
and spirocyclic heterocycles 8 and 9 respectively. a 
 
Entry Concentration (M) AIBN PhSH Product Ratio 
  (Equiv.) (Equiv.) 6-endo (8) 5-exo (9) 
1 0.2 0.3 5 100 0 
2 0.1 0.3 5 100 0 
3 0.05 0.3 5 56 44 
4 0.03 0.3 5 11 89 
5 0.05 0.5 5 48 52 
6 0.05 0.1 5 100 0 
7 0.05 1.0 5 42 58 
8 0.05 1.5 5 13 87 
9 0.05 1.5 50 0 100 
10 0.05 0.1 50 94 6 
a Ratios of 8 and 9 were determined from the 1H-NMR spectrum of the crude 
reaction mixture. All reactions were carried out at 80 ºC in toluene for 2 
hours by direct addition of reagents.  
Evaluation of the effects of reaction concentration (Table 1, 
entries 1-3) on the ratio of 8 and 9, showed that only the 6-endo 
product 8 was formed at higher concentrations, but under more 
dilute conditions (entries 3-4), the ratio of 8:9 changed to a 
more favorable 11:89 ratio of the two products. At this point, it 
was evident that the reaction was tunable and either the product 
of 5-exo or 6-endo addition could be readily selected. Simple 
variation of the amount of AIBN (Table 1, entries 4-8), whilst 
the amount of thiophenol and the reaction concentration were 
kept constant also insinuated that the radical cyclisation could 
be tuned easily. The kinetic 5-exo spirocycle was favoured at 
higher concentrations of AIBN, suggesting that the cyclised 
product is rapidly trapped and that the reaction itself is 
reversible. However, when the concentration of AIBN is low, 
the rate of cyclisation and subsequent reduction is slow and 
accordingly, the more stable thermodynamic 6-endo product 
predominates. To confirm the effects of the equivalents of 
AIBN on the reaction outcome, a large excess of thiophenol 
was used whilst varying the amount of AIBN (Table 1, entries 
9-10). There was little difference on the reaction outcome when 
50 equivalents of thiophenol were used, with selectivity easily 
tuned for either 5-exo or 6-endo addition. 
With confirmation that the equivalents of AIBN and reaction 
concentration were critical, the reaction was carried out on a 
larger scale to fully isolate and characterise both products. As 
predicted, the tricyclic heterocycle 8 was obtained in 62% 
isolated yield when the reaction was carried out with 0.1 
equivalents of AIBN. On repeating the reaction, but with 
conditions tuned for the synthesis of the spirocyclic product, 
compound 9 was isolated in 47% yield. A second product - 17 
was also observed following purification, which corresponded 
to the double bond isomer, in 18% yield, from the parent 
compound 9. On contact with silica, the double bond undergoes 
a 1,3-hydride shift to give 17 and both products in a combined 
yield of 64%. 
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Scheme 3 Selection for 6-endo or 5-exo cyclisation 
In summary, we have developed a novel approach towards the 
synthesis of pyrroloquinoline and spirocyclic heterocycles 
using tin-free radical methodology, starting from a common 
precursor. This short flexible reaction sequence will provide a 
rapid approach to structurally diverse compounds of significant 
interest and the application of this methodology is currently 
under active investigation using other heterocyclic motifs. 
Examination of their corresponding biological effects and the 
results obtained will be reported in due course. 
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